Purchase Order 75F40120P00076
- Not listed
- This firm fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Flownamics Analytical Instruments Inc., a small business manufacturer of analytical instruments and software solutions, for a SEGFLOW AUTOSAMPLER. The $155,134.00 contract has a completion date of May 31, 2017 and falls under the FDA's SEGFLOW AUTOSAMPLER major program. As a total small business set-aside award, this contract leverages Flownamics' expertise in providing specialized scientific...
- This federal contract award is for the procurement of an aseptic autosampler, the Seg-Flow 4800 with necessary accessories, by the Food and Drug Administration (FDA). The $191,403.42 firm fixed-price purchase order was awarded to Flownamics Analytical Instruments Inc., a small business manufacturer of analytical instruments and software solutions, on April 23, 2020. The original solicitation was set aside for total small business participation. The Seg-Flow 4800 autosampler is intended to...
- This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Flownamics Analytical Instruments Inc., a for-profit manufacturer of goods. The $45,388.93 contract is for CDER FLOWNAMICS OPC SOFTWARE, with an ultimate completion date of August 31, 2025. Flownamics is a small business that has previously held other FDA contracts, some of which were set aside for small businesses. This purchase order is not associated with a larger contract vehicle, and there is no...
- <p>The U.S. Department of Health and Human Services Food and Drug Administration awarded a $123,346.76 firm-fixed-price purchase order contract to Flownamics Analytical Instruments Inc., a small business manufacturer, for the acquisition of equipment and software. The contract was set aside for small businesses. The contract has a completion date of July 12, 2019 and was awarded on June 5, 2019. The place of performance is Silver Spring, Maryland.</p>
- The U.S. Food and Drug Administration (FDA) awarded a $42,455 firm-fixed-price purchase order to Fluigent, Inc., a foreign-owned for-profit organization, for the procurement of microfluidic equipment for organ-on-a-chip studies. This contract, awarded on July 13, 2024, has a completion date of July 14, 2025 and was not set aside for any specific business category. Fluigent, Inc. is a specialized provider of microfluidic solutions, including automated perfusion systems, pressure generators, and...
- The Department of Health and Human Services Food and Drug Administration awarded a $113,000 purchase order contract to Yokogawa Fluid Imaging Technologies, Inc. for a FLOWCAM light obscuration system. As a small business subsidiary of Yokogawa Electric Corp., Yokogawa Fluid Imaging will deliver its optical particle characterization technology to the FDA's facilities in Silver Spring, Maryland under the one-year contract with an estimated completion date of November 2024. The firm-fixed price...
- The Food and Drug Administration (FDA) awarded a $291,716 firm fixed-price purchase order to Government Scientific Source Inc., a small business laboratory supplier based in Reston, Virginia, for operational parts and components supporting the agency's Sartorius AMBR15 and AMBR250 single-use bioreactor systems. The contract, awarded on September 23, 2024, with completion targeted for September 22, 2027, will supply critical consumables and spare parts including AMBR15 cell culture...
- The U.S. Food and Drug Administration (FDA) awarded a $435,299.80 firm-fixed-price purchase order to Trajan Scientific Americas Inc., a foreign-owned small business manufacturer of scientific and medical devices, for the supply of a liquid chromatograph-gas chromatograph with flame ionization detector. This equipment will be used by the FDA for the analysis of mineral oil hydrocarbons (MOH) and sterols in fats and oils. The contract has a period of performance through September 10, 2025. This...
- The U.S. Food and Drug Administration (FDA), an agency of the Department of Health and Human Services (HHS), has awarded a firm fixed-price purchase order valued at $25,749.97 to Agilent Technologies Inc. for a CFSAN-2023-118815-BNE-GC-MSMS flow modulator. The contract period of performance runs from July 19, 2023 through September 29, 2024. As the prime contractor, Agilent Technologies Inc. will deliver the specified flow modulator to the FDA's Center for Food Safety and Applied Nutrition...
- The Department of Health and Human Services Food and Drug Administration awarded a $243,955.00 firm fixed price purchase order to Postnova Analytics Inc. for a TF2000 Thermal Field-Flow Fractionation System. This was a full and open competition solicitation for commercial items under Federal Acquisition Regulation (FAR) Parts 12 and 13. The North American Industry Classification System (NAICS) code is 334516 Analytical Laboratory Instrument Manufacturing. Postnova Analytics Inc. is a...
The U.S. Food and Drug Administration (FDA) awarded a $65,693.99 firm fixed-price purchase order to Flownamics Analytical Instruments Inc., a for-profit manufacturer of analytical instruments and software solutions. The contract is for the maintenance of a Flownamics SEG-FLOW aseptic bioreactor autosampler over a base period plus four option years, with a final completion date of February 6, 2025. Flownamics, a Subchapter S Corporation, has previously secured several contracts with the FDA, demonstrating its expertise in bioreactor operations, fermentation analysis, and aseptic sampling technologies, which are critical for pharmaceutical and biotechnology research and development. This award highlights the agency's ongoing need for specialized equipment and maintenance support for its bioprocessing and analytical capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Close Out | $0 | 11/12/24 | |
| P00003 | Exercise an Option | $22.5k | 1/5/22 | |
| P00002 | Other Administrative Action | $0 | 6/1/21 | |
| P00001 | Exercise an Option | $21.9k | 2/4/21 | |
| Not listed | Not listed | $21.3k | 2/7/20 |